Registered entities
Adimab, Llc
Reg. No. 80-0669559United States
Innovation
73 patent families (26 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace steady. Cited 21,169 times.
| Year | Filings |
|---|---|
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 14 |
| 2018 | 26 |
| 2019 | 22 |
| 2020 | 25 |
| 2021 | 21 |
| 2022 | 19 |
| 2023 | 30 |
| 2024 | 24 |
| 2025 | 29 |
| 2026 | 5 |
Social engagement
Social engagement: 8.5K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Orbimed, Borealis Ventures, Polaris Partners, Google Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 67% |
| Private equity | 1 | 8% |
| Angel & family office | 1 | 8% |
| Accelerator & incubator | 1 | 8% |
| Other / undisclosed | 1 | 8% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
5 Dec 2025 · Antibody Machine Learning Graduate Student Internship · Mountain View
Based on job postings tracked across public sources.
Recent activity
25 Jun 2026
Partnership
Innovent
22 Jun 2026
Event
BIO2026
8 Jun 2026
Event
World Bispecifics & TCE Summit